Related Experiment Video
Updated: Jun 24, 2026
11:05
Tissue-simulating Phantoms for Assessing Potential Near-infrared Fluorescence Imaging Applications in Breast Cancer Surgery
Published on: September 19, 2014
Tumor-targeted quantum dots can help surgeons find tumor boundaries
Donna J Arndt-Jovin1, Sven R Kantelhardt, Wouter Caarls
1Laboratory of Cellular Dynamics, Max Planck Institute for Biophysical Chemistry, Goettingen 37077, Germany.
IEEE Transactions on Nanobioscience
|March 24, 2009
Summary
Quantum dots (QDs) targeting the epidermal growth factor receptor (EGFR) can precisely label glioblastoma cells. This allows for better visualization of tumor margins, improving surgical resection and patient outcomes.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Malignant brain tumors, including glioblastoma multiforme, have a poor prognosis despite advances in surgery and adjuvant therapies.
- Neurological deterioration is severe, and recurrence rates exceed 95% due to incomplete tumor resection.
- Current imaging techniques fail to identify residual tumor cells intraoperatively, hindering complete tumor removal.
Purpose of the Study:
- To develop a novel method for intraoperative identification of malignant glial tumor cells.
- To evaluate the efficacy of quantum dots (QDs) conjugated with epidermal growth factor (EGF) or anti-EGFR antibodies for tumor cell labeling.
Main Methods:
- Quantum dots (QDs) were coupled to epidermal growth factor (EGF) or anti-epidermal growth factor receptor (EGFR) antibodies.
- The QDs were tested for their ability to specifically label glial tumor cells in vitro (cell culture), in vivo (glioma mouse models), and ex vivo (human brain-tumor biopsies).
Main Results:
- EGFR-targeted QDs specifically and sensitively labeled glial tumor cells across all tested models.
- The fluorescence emission from the QDs provided clear demarcation between tumor and healthy brain tissue at both macroscopic and cellular levels.
- This targeted labeling facilitated the identification of residual tumor cells, crucial for surgical planning and execution.
Conclusions:
- EGFR-targeted quantum dots offer a promising tool for intraoperative visualization and precise resection of malignant brain tumors.
- This approach has the potential to improve surgical outcomes and reduce recurrence rates for glioblastoma patients.
- Further clinical translation of QD-based imaging could revolutionize neurosurgical oncology.
